These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluating the Immunogenicity and Safety of a Smallpox Vaccine to Monkeypox in Healthy Japanese Adults: A Single-Arm Study. Tomita N; Morino E; Terada-Hirashima J; Uemura Y; Shimizu Y; Saito S; Suzuki T; Okumura N; Iwasaki H; Ebihara H; Shimojima M; Sugiura W; Ohmagari N; Ujiie M Life (Basel); 2023 Mar; 13(3):. PubMed ID: 36983942 [TBL] [Abstract][Full Text] [Related]
3. Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults. Kennedy JS; Gurwith M; Dekker CL; Frey SE; Edwards KM; Kenner J; Lock M; Empig C; Morikawa S; Saijo M; Yokote H; Karem K; Damon I; Perlroth M; Greenberg RN J Infect Dis; 2011 Nov; 204(9):1395-402. PubMed ID: 21921208 [TBL] [Abstract][Full Text] [Related]
4. A Single Vaccination of Nonhuman Primates with Highly Attenuated Smallpox Vaccine, LC16m8, Provides Long-term Protection against Monkeypox. Iizuka I; Ami Y; Suzaki Y; Nagata N; Fukushi S; Ogata M; Morikawa S; Hasegawa H; Mizuguchi M; Kurane I; Saijo M Jpn J Infect Dis; 2017 Jul; 70(4):408-415. PubMed ID: 28003603 [TBL] [Abstract][Full Text] [Related]
5. Clinical and immunological response to attenuated tissue-cultured smallpox vaccine LC16m8. Saito T; Fujii T; Kanatani Y; Saijo M; Morikawa S; Yokote H; Takeuchi T; Kuwabara N JAMA; 2009 Mar; 301(10):1025-33. PubMed ID: 19278946 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of the Smallpox Vaccine for Postexposure Prophylaxis in Monkeypox: Protocol for an Open-Labeled, Single-Armed Study. Yano R; Terada-Hirashima J; Uemura Y; Tomita N; Shimizu Y; Iwasaki H; Okumura N; Suzuki T; Saito S; Ujiie M; Sugiura W; Ohmagari N JMIR Res Protoc; 2023 Aug; 12():e46955. PubMed ID: 37624623 [TBL] [Abstract][Full Text] [Related]
7. Profiling of the antibody response to attenuated LC16m8 smallpox vaccine using protein array analysis. Eto A; Fujita M; Nishiyama Y; Saito T; Molina DM; Morikawa S; Saijo M; Shinmura Y; Kanatani Y Vaccine; 2019 Oct; 37(44):6588-6593. PubMed ID: 31540810 [TBL] [Abstract][Full Text] [Related]
8. Recent advances in the study of live attenuated cell-cultured smallpox vaccine LC16m8. Eto A; Saito T; Yokote H; Kurane I; Kanatani Y Vaccine; 2015 Nov; 33(45):6106-11. PubMed ID: 26319072 [TBL] [Abstract][Full Text] [Related]
9. Early evaluation of the safety, reactogenicity, and immune response after a single dose of modified vaccinia Ankara-Bavaria Nordic vaccine against mpox in children: a national outbreak response. Ladhani SN; Dowell AC; Jones S; Hicks B; Rowe C; Begum J; Wailblinger D; Wright J; Owens S; Pickering A; Shilltoe B; McMaster P; Whittaker E; Zuo J; Powell A; Amirthalingam G; Mandal S; Lopez-Bernal J; Ramsay ME; Kissane N; Bell M; Watson H; Ho D; Hallis B; Otter A; Moss P; Cohen J Lancet Infect Dis; 2023 Sep; 23(9):1042-1050. PubMed ID: 37336224 [TBL] [Abstract][Full Text] [Related]
10. Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus. Chiuppesi F; Zaia JA; Gutierrez-Franco MA; Ortega-Francisco S; Ly M; Kha M; Kim T; Dempsey S; Kar S; Grifoni A; Sette A; Wussow F; Diamond DJ Commun Med (Lond); 2024 Feb; 4(1):19. PubMed ID: 38366141 [TBL] [Abstract][Full Text] [Related]
11. Current Status of Vaccine Development for Monkeypox Virus. Rastogi A; Kumar M Adv Exp Med Biol; 2024; 1451():289-300. PubMed ID: 38801585 [TBL] [Abstract][Full Text] [Related]
12. Freeze-dried live attenuated smallpox vaccine prepared in cell culture "LC16-KAKETSUKEN": Post-marketing surveillance study on safety and efficacy compliant with Good Clinical Practice. Nishiyama Y; Fujii T; Kanatani Y; Shinmura Y; Yokote H; Hashizume S Vaccine; 2015 Nov; 33(45):6120-7. PubMed ID: 26455406 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of monkeypox- and vaccinia-virus neutralizing antibodies before and after smallpox vaccination: A sero-epidemiological study. Marchi S; Piccini G; Cantaloni P; Guerrini N; Zannella R; Coluccio R; Benincasa L; Solfanelli N; Remarque EJ; Viviani S; Kistner O; Temperton N; Montomoli E; Manenti A; Trombetta CM J Med Virol; 2024 Jun; 96(6):e29728. PubMed ID: 38860589 [TBL] [Abstract][Full Text] [Related]
14. Serological responses in humans to the smallpox vaccine LC16m8. Johnson BF; Kanatani Y; Fujii T; Saito T; Yokote H; Smith GL J Gen Virol; 2011 Oct; 92(Pt 10):2405-2410. PubMed ID: 21715598 [TBL] [Abstract][Full Text] [Related]
15. LC16m8, a highly attenuated vaccinia virus vaccine lacking expression of the membrane protein B5R, protects monkeys from monkeypox. Saijo M; Ami Y; Suzaki Y; Nagata N; Iwata N; Hasegawa H; Ogata M; Fukushi S; Mizutani T; Sata T; Kurata T; Kurane I; Morikawa S J Virol; 2006 Jun; 80(11):5179-88. PubMed ID: 16698998 [TBL] [Abstract][Full Text] [Related]